Cargando…
Is it Time for Trials on Preventing Immune-Mediated Myocardial Damage?
[Figure: see text]
Autores principales: | Peyster, Eliot G., Margulies, Kenneth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246058/ https://www.ncbi.nlm.nih.gov/pubmed/34222725 http://dx.doi.org/10.1016/j.jacbts.2021.05.005 |
Ejemplares similares
-
Reply: In Situ Immune Profiling Identifies Immune Players Involved in Allograft Rejection: A Call for Precision Medicine
por: Peyster, Eliot G., et al.
Publicado: (2020) -
Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection
por: Peyster, Eliot G., et al.
Publicado: (2018) -
In Situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy and Rejection Risk Stratification
por: Peyster, Eliot G., et al.
Publicado: (2020) -
Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Truitt, Rachel, et al.
Publicado: (2018) -
TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis
por: Ma, Xiucui, et al.
Publicado: (2021)